Sertraline- and mirtazapine-induced severe neutropenia [4]

American Journal of Psychiatry

Volumn 162, Issue 7, 2005, Pages 1386-

  Ozcanli, Tuba ^a   Unsalver, Baris ^a   Ozdemir, Samuray ^a   Ozmen, Mine ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MIRTAZAPINE; SERTRALINE; SULTAMICILLIN;

ADULT; BLOOD CELL COUNT; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG CHOICE; DRUG WITHDRAWAL; FEMALE; GRANULOCYTE; HAMILTON SCALE; HUMAN; LETTER; MAJOR DEPRESSION; MEDICAL DECISION MAKING; NEUTROPENIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

EID: 21344474568     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.162.7.1386     Document Type: Letter

References (6)

1. Albertini RS, Penders TM: Agranulocytosis associated with tricyclics. J Clin Psychiatry 1978; 39:483-485
2. Adams PC, Robinson A, Reid MM, Vishu MC, Livingston M: Blood dyscrasias and mianserin. Postgrad Med J 1983; 59:31-33
3. Nelson JC: Safety and tolerability of the new antidepressants. J Clin Psychiatry 1997; 58:26-31
4. Anghelescu I, Klawe C, Dahmen N: Venlafaxine in a patient with idiopathic leukopenia and mirtazapine-induced severe neutropenia (letter). J Clin Psychiatry 2002; 63:838
5. Davis J, Barkin RL: Clinical pharmacology of mirtazapine: revisited (letter). Am Fam Physician 1999; 60:1101
6. Draper BM, Manoharan A: Neutropenia with cross-intolerance between two tricyclic antidepressant agents (letter). Med J Aust 1987; 146:452-453